Wake Network, Inc.: Clinical Trials

1 trial sponsored by Wake Network, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Wake Network, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
PSIL428, Oyster mushroom - Anxiety and Depression
Phase 2WithdrawnWake Network, Inc.2022-09-152022-06-30

Conditions studied

Anxiety Disorders (1)  ·  Depression (1)

Interventions

pleurotolysin B, oyster mushroom (1)

Countries

Jamaica (1)

Top investigators

Roger Gibson (1)  ·  Sharon White (1)